SENSEX NIFTY
GlaxoSmithKline Consumer Healthcare > Company History > Food Processing > Company History of GlaxoSmithKline Consumer Healthcare - BSE: 500676, NSE: GSKCONS
YOU ARE HERE > MONEYCONTROL > MARKETS > FOOD PROCESSING > COMPANY BACKGROUND - GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare
BSE: 500676|NSE: GSKCONS|ISIN: INE264A01014|SECTOR: Food Processing
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 19, 16:30
5717.90
55.5 (0.98%)
VOLUME 803
LIVE
NSE
Dec 19, 16:30
5720.20
60.15 (1.06%)
VOLUME 7,088
Company History - GlaxoSmithKline Consumer Healthcare
1948
 
 - Beecham (India) Pvt. Ltd., was incorporated at Mumbai on 8th
 December, under the name Group Laboratories (India) Pvt. Ltd., as a
 wholly owned subsidiary of Harold F. Ritchie (India) Ltd., which in
 turn was a wholly owned subsidiary of Beecham Group, Ltd., U.K.  The
 Company manufacture dairy and milk products, toiletries and drugs and
 pharmaceuticals.  The dairy products, are marketed under the name
 Horlicks, Elaichi Horlicks, Horlicks Tablets, Boost and Gopika ghee.
 
 1949
 
 - Since August, Beecham India Pvt. Ltd., had been manufacturing
 products such as Brylcreem Haircream, Eno fruit salt, Pure Silvikrin,
 Silvikrin hair dressing, Macleans tooth paste and Macleans brand
 indigestion powder under technical and marketing know-how from
 Beecham Group, Ltd. U.K.
 
 1958
 
 - The Smithkline Beecham Consumer Healthcare Ltd. was Incorporated on
 30th October, as a private limited company under the name Hindustan
 Milkfood Manufacturers, Pvt. Ltd.  It became a public limited company
 on 28th March 1961.  It was promoted by Horlicks, Ltd., U.K., mainly
 to manufacture and sell malted milk food under the brand name
 Horlicks  which had hitherto been imported.
 
 - The Company was incorporated in 1958 with a paid-up capital of Rs.
 12 lakhs.
 
 1960
 
 - The name of Group Laboratories (India) Pvt. Ltd., was changed to
 Beecham (India) Pvt. Ltd. with effect from 2nd January. 
 
 1963
 
 - The capital was increased by Rs 2 lakhs, comprising of 20,000
 shares of Rs 10 each, through private placements to Indian
 residents/financial institutions out of which 2,500 shares of Rs 10
 each were issued as rights at par and 5,000 shares of Rs 10 each were
 issued at a premium 
 of Rs 25 per share.  The details of the mode of issue of the
 remaining 12,500 shares is not known.
 
 1967
 
 - On 15th March, 2,10,000 bonus shares were issued in the proportion
 3:2.
 
 1968
 
 - On 6th March, 3,00,000 bonus shares were issued in the proportion
 6:7.  On 30th March, 96,174 shares were issued at a premium of Rs
 7.50 each through private placement to Indian residents/financial
 institutions.
 
 1969
 
 - The worldwide interests of Horlicks, Ltd., U.K., were purchased by
 Beecham Group, Ltd., U.K.  The subsequent association with Beecham
 Group, Ltd., U.K. provided access to additional international
 marketing expertise, worldwide experience and greater technological
 know-how and was instrumental in strengthening the development
 programme of the Company.
 
 1972
  
 - Details upto 31.3.1972 are given under Equity Capital History on
 24-11-1972, 6,17,557 Bonus shares issued in prop. 9:10, in the
 earlier years, 87,500 shares of Rs 10 each issued to Horlicks Ltd.
 without payment in cash.
 
 1977
 
 - Beecham (India) Pvt. Ltd., a wholly owned subsidiary of Beecham
 Group, Ltd., U.K., was merged with the Company effective from 1st
 April, the approval for this having been received on 1st January
 1979.
 
 - 2,36,289 shares issued at a premium of Rs 20 per share: 59,072
 shares each to LIC and UTI; 47,257 shares to GIC; 47,258 shares to
 Indian shareholders, 11,814 shares to employees of the Company and
 11,816 shares to directors, etc.
 
 1978
 
 - The Indian participation in the Company had been progressively
 increased and stood at 60% before the offer for sales of shares
 during November.
 
 - During November, Horlicks, Ltd., U.K. offered for sale to resident
 Indian nationals 6,61,608 equity shares of Rs 10 each at a premium of
 Rs 7.50 each out of its holding in the Company in the following
 manner:
 (i) 30,000 shares to the employees of the Company; (ii) 1,01,062
 shares to members of the Company not being holders of more than
 10,000 shares as on 15th June, in the proportion 1:4 (fractions being
 rounded up);
 (iii) 30,456 shares to be allotted at the discretion of the Company's
 directors on a rational and equitable basis and (iv) 5,00,000 shares
 to the public.
 
 - After the offer for sale of shares to resident Indian nationals
 during November, the non-resident holding in the Company was reduced
 to 40%.
 
 - 16,54,020 Bonus shares issued in prop. 1:1 on 12.6.1978, 1,29,886
 shares of Rs 10 each issued to Beecham Group, Ltd. U.K. on
 amalgamation of Beecham (India) Pvt. Ltd. with the Company in the
 prop. 21.65 shares of Rs 10 each of the Company to every shares of Rs
 100 each held in
 Beecham (India) Pvt. Ltd.
 
 -SBCH entered the capital market in 1978 with an offer for sale of 
 equity. It manufactures and sells malted milk food products under 
 the  Horlicks brand name.Their product range includes Eno, Brylcream,
  Horlicks, Boost, Gopika ghee, etc. 
 
 1979
 
 - The name of the Company was changed from Hindustan Milkfood
 Manufacturers, Ltd., to HMM Ltd., with effect from 1st March.
  
 1981
 
 - 17,18,963 Bonus Equity shares issued in prop. 1:2.
 
 1984
 
 - 19,33,833 bonus equity shares issued in prop. 3:8.
 
 1987
 
 - 70,90,722 bonus equity shares issued in prop. 1:1.
 
 1991
 
 - Effective 16th September, the name was again changed to Smithkline
 Beecham Consumer Brands Ltd.
 
 1994
 
 - The Company expanded its production capacity at Nabha.
 
 - Once again, the name of the Company changed from Smithkline
 Beeacham Consumer Brands Ltd. to Smithkline Beecham Consumer
 Healthcare Ltd.
 
 1995
 
 - The Company added one more line of production utilising the
 existing technology.
 
 - 141,81,444 bonus equity shares issued in the ratio of 1:1.
 
 1997
 
 - 17,10,733 No. of equity shares allotted as fully paid bonus shares
 in prop. of 3:5.
 
 - Infanrix-B, a single of this combination vaccine would protect
 children against four major infectious diseases - diphtheria,
 tetanus, acellular pertussis and hepatitis-B.
 
 - The Government has shot down SmithKline Beecham's plans of
 manufacturing and marketing pharmaceutical and over-the-counter (OTC)
 products through its already set up wholly-owned subsidiary in the
 country.
 
 - The pharma major, SmithKline Beecham (SKB), has developed a
 two-in-one hepatitis vaccine, completed evaluation trials and claims
 that it has yielded good results in providing protective cover.
 
 1998
 
 - Smithkline Beecham Consumer Healthcare (SBCH) has launched its
 Ribena brand in India with amla flavour as a refreshing health drink.
 
 
 - SBCH will be setting up the new plant on a 140-acre greenfield plot
 provided by SmithKline Beecham Asian Private Limited (SBAP), which has
 entered into a `synergistic commercial alliance' with the
 multinational's consumer healthcare company in India.
 
 - Smithkline Beecham Consumer Healthcare (SBCH) has launched its
 Ribena brand in India with amla flavour as a refreshing health drink.
 
 
 - International Healthcare major SmithKline Beecham (SB), is all set
 to launch a cluster of vaccines in India in 1998-99.  These include a
 hepatitis - A vaccine, a two in one hepatitis A & B vaccine and
 another targeted at preventing chicken pox.
 
 - SBCH will be setting up the new plant on a 140-acre greenfield plot
 provided by SmithKline Beecham Asian Private Limited (SBAP), which has
 entered into a `synergistic commercial alliance' with the
 multinational's consumer healthcare company in India.
 
 - SmithKline Beecham Consumer Healthcare Ltd, has set a second
 interim dividend for 1998 at Rs 2.60 per equity share, the Mumbai
 Stock Exchange announced.
 
 -Ribena was launched in 1998 but was subsequently withdrawn last
 year.  
 
 1999
 
 - SmithKline Beecham Consumer Healthcare Ltd (SBCH), the nutritional
 healthcare leader is setting up a state of the art spray drying
 malted food plant at Sonepat in Haryana.
 
 - SmithKline has launched Junior Horlicks for young and flavour
 variants like elaichi and chocolate.  It has also recently launched
 Amla-based Vitamin C drink Ribena from its parent's stable.
 
 - Beecham (India) Pvt Ltd, a wholly owned subsidiary of Beecham Group
 Ltd (UK) was merged with the company with effective from 1st
 April,1977.
 
 - The name of the company was changed from Hindustan Milkfood
 Manufacturers Ltd to HMM Ltd with effect from 1st March, 1979. 
 During 1994, once again, the name of the company changed to the
 present one, SmithKline Beecham Consumer Healthcare.  After a major
 development the company has decided to set a new 21,000-tonne
 Horlicks plant which 
 likely to be commissioned in 2002.
 
 - SmithKline Beecham Consumer HealthCare Ltd has taken the firm step
 toward setting up a spray drying malted food plant at Sonepat,
 Haryana. 
 
 2000
 
 - Smithkline Beecham Consumer Healthcare has launched the `Horlicks
 Plus'.
 
 - The Company enter the analgesics segment by piggybacking on Crocin,
 a paracetamol-based formulation, commonly marketed as an antipyretic.
 
 - In the oral care category, the company is marketing two additional 
 toothbrushes-- Interdental and V-cut --- under the Aquafresh brand. In
   Sep. 2000, the `Aquafresh Magic Box' promotion, the first-ever 
 scratch-and-win campaign in the toothpaste category was launched
 bySBCH. 
 
 -In Dec 2000, the parent company -- Smithkline Beecham Plc -- merged 
 with Glaxo Wellcome Plc to form GlaxoSmithkline, which holds 40% of
 the   with Glaxo Wellcome Plc to form GlaxoSmithkline, which holds
 40% of the  equity capital of SBCH. 
 
 2002
 
 - Smithkline Beecham appoints Mr Ian McPherson as a Director.
 
 - The SmithKline Beecham Consumer Healthcare (SKBCH) has undergone a
 change of name to GlaxoSmithkline Beecham Consumer Healthcare, by
 additional of Glaxo tag to itself.
 
 -The Board of Directors of Glaxo SmithKline Consumer Healthcare Ltd
 at its meeting held on August 29, 2002 have resolved for closure of
 operation of the company's undertaking situated at Kolkatta where
 packing operations of the company is being carried out with effect
 from the close of working hours on August 31, 2002.
 
 -Nick Massey appointed as Director of GlaxoSmithkline Consumer
 Healthcare wef Nov 01, 02.
 
 -GlaxoSmithKline Consumer Healthcare Ltd has informed BSE that at the
 meeting of the Board of Directors held on October 25, 2002 has taken
 on record the following changes:
 
 1. Mr Colin Handcock has ceased to be the Nominee Director of the
 Company under Article 97A of the Articles of Association of the
 Company. Consequently Mr P Dwarakanath also ceases to be Alternate
 Directors to Mr Colin Handcock, Mr Nick Massey has been nominated by
 Horlicks Ltd as a Director under Article 97A of the Articles of
 Association of the Company
 
 2. Mr Nick Massey has been appointed as the Managing Director of the
 Company effective November 01, 2002 in place of Mr S J Scarff who
 ceases to be the Managing Director of the Company w.e.f. November 01,
 2002.
 
 3. Mr S J Scarff has been appointed as the Non executive Chairman of
 the Board of Directors of the Company from that date.
 
 4. Mr Sangita Reddy has tendered her resignation w.ef. November 01,
 2002 to the Board of Directors and in her place Mr Colin Handcock has
 been appointed as a Director in casual vacancy w.e.f. November 01,
 2002. Mr P Dwarakanath has been appointed as an Alternate Director of
 Mr Colin Handcock at the above mentioned Board Meeting
 
 5. Mrs Sangita Reddy who was a member of the Investor Greivance
 Committee has ceased to be member due to her resignation and in her
 place Mr P S Mukherjee, Wholetime Director of the Company has been
 appointed as a member of the Investor Greivance Committee w.e.f.
 November 01, 2002.
 
 2003
 
 -Mr.V.Thyagarajan and Mr.R Subbarayan ceased to be the Director and
 Alternate
 Director on the Board of the Company.
 
 -GSK is phasing out  its premium toothpaste brand Aquafresh from the
 Indian Market.
 
 -GSK Ltd has informed that Mr. Abhinandan Chatterjee, Director of
 Finance and 
 Information Technology  has desired to take early retirement from the
 services
 of the company.
 
 -Horlicks, the flagship brand of GlaxoSmithKline which slipped from
 10th position to 
 16th position  in the brand equity survey of India has been
 relaunched by the 
 company.
 
 -Mr. Gautam K Chakraborty has been appointed as a wholetime director
 in the casual vacancy created by the resignation of Mr. A
 Chatterjee.
 
 -Qualigens Fine Chemicals (QFC), a division of GlaxoSmithKline (GSK)
 India, that manufactures and markets research and laboratory
 chemicals and lab-ware has inked a marketing agreement with Honeywell
 Burdick & Jackson
 
 2004
 
 -GlaxoSmithKline Consumer Healthcare launches boost energy shake     
                          
 
 2005
 
 -GlaxoSmithkline launches variant of Horlicks at Visakhapatnam
 
 - GlaxoSmithKline has set up a cricket academy that aims to find and
 nurture cricketing talent among the youth.
 
 2006
 
 -GSK enters into five years agreement with Genpact
 
 -GlaxoSmithkline Consumer Healthcare Ltd has appointed Mr Zubair
 Ahmed as the Managing Director of the Company.
 
 -Glaxo SmithKline Consumer Healthcare has re-launched its Junior
 Horlicks 1-2-3 with a new packaging. This is for the first time that
 a health drink for pre-school kids was introduced in India.
 
 
 2007
 
 -GlaxoSmithkline Consumer Healthcare Ltd has informed that the
 Company has appointed Karvy Computershare Pvt Ltd (KCPL), Hyderabad
 as the Company's Registrar & Transfer Agent (RTA) w.e.f. September
 01, 2007.
 
 2010
 
 - An investment of Rs 300 crore to be done by the GlaxoSmithKline
 Consumer Healthcare for the purpose of re-launching Horlicks as a
 bigger brand, which will be comprising of its category of food and
 beverage products as stated by Mr Shubhajit Sen who is the Executive
 Vice- President, Marketing. 
 
 - GlaxoSmithKline Consumer Healthcare (GSKCH) has said on Monday that
 it is planning to invest over Rs 300 crore for relaunching the
 Horlicks brand with a new look and repositioning the original milk
 food drink as the company’s umbrella brand.
 
 - In a bid to obtain a more lavish product spread GlaxoSmithKline
 Consumer Healthcare (GSKCH) is planning to enter the premium,
 highmargin biscuits and cookies market. The company has already
 entered the instant noodles, snack bars and low-priced milk-food
 drinks categories over recent months.
 
 2011
 
 - GSk has launched a Sensodyne, it was launched in an attempt to
 enter the Indian tooth paste market. This was GSK’s second attempt to
 enter Rs 1,850-crore toothpaste market. The product will be directly
 competing with the Colgate Company’s product Sensitive. Prior to the
 new launch, the Aqua fresh toothpaste launched by GSK did not got the
 consumer acceptance and was out of the market.
 
 - GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that on
 January 06, 2011 several newspapers carried Articles and interviews
 around launch of Sensodyne® Sensitive Toothpaste by GSK in India. In
 this regard, the Company clarify that, the launch has been done by
 GSK Asia Private Ltd., Company's Associate Company in India and not
 by GlaxoSmithkline Consumer Healthcare Ltd. as reported in some
 newspapers.
 
 2012
 
 - UK based GSK Plc, maker of popular FMCG products like Horlicks and
 Sensodyne, has been planning to raise its stake in its Indian unit
 GlaxoSmithKline Consumer Healthcare to 75 per cent through an open
 offer.
Source : Dion Global Solutions Limited
Quick Links for GlaxoSmithKline Consumer Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.